Company Quick10K Filing
Prime Global Capital Group
10-Q 2020-01-31 Filed 2020-03-18
10-K 2019-10-31 Filed 2020-02-03
10-Q 2019-07-31 Filed 2019-09-16
10-Q 2019-04-30 Filed 2019-06-14
10-Q 2019-01-31 Filed 2019-03-14
10-K 2018-10-31 Filed 2019-01-29
10-Q 2018-07-31 Filed 2018-09-07
10-Q 2018-04-30 Filed 2018-06-15
10-Q 2018-01-31 Filed 2018-03-20
10-K 2017-10-31 Filed 2018-01-30
10-Q 2017-07-31 Filed 2017-09-19
10-Q 2017-04-30 Filed 2017-06-13
10-Q 2017-01-31 Filed 2017-03-21
10-K 2016-10-31 Filed 2017-02-10
10-Q 2016-07-31 Filed 2016-09-14
10-Q 2016-04-30 Filed 2016-06-14
10-Q 2016-01-31 Filed 2016-03-17
10-K 2015-10-31 Filed 2016-01-29
10-Q 2015-07-31 Filed 2015-09-14
10-Q 2015-04-30 Filed 2015-06-09
10-Q 2015-01-31 Filed 2015-03-10
10-K 2014-10-31 Filed 2015-01-20
10-Q 2014-07-31 Filed 2014-09-15
10-Q 2014-04-30 Filed 2014-06-11
10-Q 2014-01-31 Filed 2014-03-14
10-K 2013-10-31 Filed 2013-12-24
10-Q 2013-07-31 Filed 2013-09-16
10-Q 2013-04-30 Filed 2013-06-07
10-Q 2013-01-31 Filed 2013-03-12
10-K 2012-10-31 Filed 2012-12-31
10-Q 2012-07-31 Filed 2012-09-10
10-Q 2012-04-30 Filed 2012-06-11
10-Q 2012-01-31 Filed 2012-03-09
10-K 2011-10-31 Filed 2012-01-31
10-Q 2011-07-31 Filed 2011-09-14
10-Q 2011-04-30 Filed 2011-06-09
10-Q 2011-01-31 Filed 2011-03-17
10-Q 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-06-29
10-Q 2009-12-31 Filed 2010-02-12
8-K 2020-07-15
8-K 2020-05-29
8-K 2019-09-18
8-K 2018-09-20

Prime Global Capital Group Financials

PGCG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash2,9892,5932,8319,1741,3378969168106604,4454,4153,2791,7859342,4151,8328374556803326863862951762942931471875031561,321186
Accounts Receivable27131763383731421077121,2352171,0661,0991,029112120130163137134137138155143111631321
Inventory
PP&E24024623722330,65957,88158,54960,14761,21257,96158,83359,62559,33755,45656,27450,01159,33746,13348,79747,15945,55243,13544,00844,63445,15848,98348,71947,11645,69746,74346,25646,368
Assets6,0647,4387,98517,19041,58560,55261,30961,81961,74362,98263,99564,16861,17256,26260,40953,23447,08748,25450,55748,17745,81242,97043,62944,04944,52048,06347,39045,76844,97345,50846,09544,988
Accounts Payable92351795210128533000016000000031212121
Long-Term Debt812875860814845
Liabilities5981,0139952,9052,95121,26722,01924,71625,52222,51223,21023,20020,53018,18722,31620,45318,45018,75319,43318,34717,29216,18916,54716,63417,23018,57418,37517,80117,92717,91018,84017,708
Stockholders' Equity5,4676,4256,99014,28538,63439,28539,28937,10336,22140,68740,95441,13140,74838,20638,22232,89128,75229,63431,26729,97828,68226,95227,26827,61527,51429,74129,28528,22927,29327,85027,50327,526
Income Statement ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Revenue3012,1032486151,6301,700128771282021,008626607537497505381413435436362327299289351348297460452460941
Cost of Revenue15103641299426414642104184561301143379515172122126210132175122200162188151147174375
Gross Profit2862,1041844861,5361,674155318798824559477424464426-133240313310152195125167151179102303299280559
R&D
SG&A281333305312484258399864461848456143613633318-51913014112623011116818013597168116123100188
Tax6501210827763-29-1475380143006373251168395919398956812322548100
Net Income131,407-54455986852-243-976-1,384-63626-193-194-519-443-108-523-149-117-220-426-171-285-41-463-127-294-85-64-53-38
Cash Flow ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash Operating1,937-115-214359291-411-584-412463-577-1,211-497-446-39463-712935-155-115-271-113-36-41-73-117924
Cash Investing-2,174331-1,879-19,05248-3,1832936,03914714491-1873-372-2,402-134992399601-4-38-12-45-29-28-19-22
Cash Financing-6268,52418,256-3083,49692-1,740-642-462-755-3191,863-2751,249-309-351-598-434-15118126129-57148-2071,095-1,121